electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
electroCore (ECOR) was upgraded by Zacks Research from "strong sell" to "hold".